Bokep
Treatment Considerations
Percentages based on incidence data from 1978-2001 collected in the 9 …
Efficacy
YONDELIS ® (trabectedin) study design 1. YONDELIS ® was studied in a phase 3 …
Safety
The safety of YONDELIS ® was evaluated in 755 patients. YONDELIS ® was …
Dosing and Administration
Recommended starting dose and schedule for administering YONDELIS® …
MOA
YONDELIS ® (trabectedin) is an alkylating drug that binds guanine residues in the …
Janssen CarePath
Affordability support to help your patients start and stay on the Janssen treatment …
Resources
Resources for health care professionals and doctors prescribing YONDELIS® …
Patients
YONDELIS ® is a prescription medicine …
- Generic Name: Trabectedin
Trabectedin is used to treat certain types of cancer.
May Treat: Leiomyosarcoma · Liposarcoma
Drug Class: Antineoplastic-Alkylating Agent-Tetrahydroisoquinoline and Derivatives
Availability: Prescription Required
Pregnancy: Consult your doctor. This medication may be harmful to an unborn child.
Lactation: This drug should not be given to breastfeeding mothers
Alcohol: Limit intake while taking this medication
Driving: May cause drowsiness or dizziness. Use caution
Manufacturer: JANSSEN PRODUCT
PrecautionsFor informational purposes only. Consult a medical professional for advice.
Source: First Databank Learn more
Yondelis - Chemocare
How Does YONDELIS® Infusion Therapy Work? | YONDELIS®
Yondelis® Approved for Treatment of Soft Tissue …
WebCancerConnect. Aug 2, 2018. Home. Sarcoma. The United States Food and Drug Administration (FDA) approved the chemotherapy agent, Yondelis® (trabectedin), for the treatment of liposarcoma and …
Yondelis: Uses, Dosage & Side Effects - Drugs.com
Welcome to Janssen CarePath | Janssen CarePath for …
Google Maps
Simi Valley, California - Wikipedia
Interactive Map of the San Andreas Fault - Thule Scientific
Yondelis | European Medicines Agency
MICHELIN Simi Valley map - ViaMichelin